April 2026—Illumina has launched TruPath Genome, which provides high-quality, comprehensive whole genome insights for genetic disease. It features a hands-on time of about 10 minutes and generates 16 whole genomes per day. The technology leverages novel on-flow-cell library preparation with patterned flow-cell technology and advanced informatics to seamlessly add long-distance insights for comprehensive variant detection. DRAGEN algorithms tuned to incorporate proximity information from TruPath flow cells improve read alignment and variant calling, extending high-quality reads to difficult-to-map regions, variant phasing, structural variants, short tandem repeats, and clinically relevant paralogous genes. TruPath Genome fully phases up to 98 percent of genes.
Illumina, 800-809-4566